Health 2.0’s Role in a World of “Data Liberacion”

This panel includes speakers Kenneth Buetow (Associate Director, BioInformatics, National Cancer Institute & Founder, caBIG), Patrick Soon-Shiong (Executive Chairman, Abraxis Health), and Josh Sommer (Executive Director, Chordoma Foundation). Coming together to discuss how the Health 2.0 community can get involved in working with data and services, this panel approaches the issue from a variety of perspectives.

Patients 2.0

Ever since Health 2.0 started conferences, we’ve been asked to feature the voice of the patient. For this conference we got out of the way completely and asked Gilles Frydman to find us some great patients and caregivers to talk about their experiences and hopes for innovation. So here’s your opportunity to hear five vocal ePatients who will share their personal journeys and experiences navigating the healthcare system and the world of Health 2.0. We promise you will not be disappointed.

The Future of Research – Part 2

The emergence of user-generated content, and the rise of patient involvement in Health 2.0 is radically changing research in both discovery and clinical practice. It’s raising important questions. What is peer review? What is evidence? And what’s appropriate methodology in a world in which data are being generated and released from so many diverse sources so quickly? We’ll be looking across the spectrum from genomics to clinical trial recruiting all the way to clinical research and decisions made by providers and consumers in everyday practice.

The Future of Research

The emergence of user-generated content, and the rise of patient involvement in Health 2.0 is radically changing research in both discovery and clinical practice. It’s raising important questions. What is peer review? What is evidence? And what’s appropriate methodology in a world in which data are being generated and released from so many diverse sources so quickly? We’ll be looking across the spectrum from genomics to clinical trial recruiting all the way to clinical research and decisions made by providers and consumers in everyday practice.

thumbnail_2_735c04f7_v1

Health 2.0’s Role in a World of “Data Liberacion̶ ...

This panel includes speakers Kenneth Buetow (Associate Director, BioInformatics, National Cancer Institute & Founder, caBIG), Patrick Soon-Shiong (Executive Chairman, Abraxis Health), and Josh Sommer (Executive Director, Chordoma Foundation). Coming together to discuss how the Health 2.0 community can get involved in working with data and services, this panel approaches the issue from a variety of perspectives.

thumbnail_2_64063c63_v1

Patients 2.0

Ever since Health 2.0 started conferences, we’ve been asked to feature the voice of the patient. For this conference we got out of the way completely and asked Gilles Frydman to find us some great patients and caregivers to talk about their experiences and hopes for innovation. So here’s your opportunity to hear five vocal ePatients who will share their personal journeys and experiences navigating the healthcare system and the world of Health 2.0. We promise you will not be disappointed.

thumbnail_2_9d8c0f2e_v5

The Future of Research – Part 2

The emergence of user-generated content, and the rise of patient involvement in Health 2.0 is radically changing research in both discovery and clinical practice. It’s raising important questions. What is peer review? What is evidence? And what’s appropriate methodology in a world in which data are being generated and released from so many diverse sources so quickly? We’ll be looking across the spectrum from genomics to clinical trial recruiting all the way to clinical research and decisio ...
thumbnail_2_902d6044_v19

The Future of Research

The emergence of user-generated content, and the rise of patient involvement in Health 2.0 is radically changing research in both discovery and clinical practice. It’s raising important questions. What is peer review? What is evidence? And what’s appropriate methodology in a world in which data are being generated and released from so many diverse sources so quickly? We’ll be looking across the spectrum from genomics to clinical trial recruiting all the way to clinical research and decisio ...